Drugs marketed under international unpatented name Tropicamide are now listed as medications requiring name-specific and quantitative accounting at healthcare institutions.
The new regulation was issued per Directive of the Ministry of Healthcare of Ukraine No 845 of 29.10.2012 on the amendment of the Rules of Issuing Prescriptions and Orders for Medicinal Products and Medical Devices and of the Procedure of Selling Medicinal Products and Medical Devices at Drugstores and their Subdivisions approved by Directive of the Ministry of Healthcare of Ukraine No 360 of 19.07.2005, the press service of Apteka weekly reports.
Just as a reminder, the above document will come into force as of the official publication date. It is expected to be published in The Official Journal of Ukraine, issue No 87 dated 23.11.2012.
The 6th Conference of Farmak School of Young Scientists was held on 1 November 2018. 130 guests and employees of Farmak JSC attended the event; 26 reports were presented. This conference already enjoys popularity among students, young scientists, and post-graduate students. The School of Young Scientists is a platform for presenting scientific achievements a...
The strategic goal of Farmak JSC is to expand exports to the EU and to enter new markets Imposition of sanctions on Farmak JSC will not affect the company’s strategy and operations. Farmak JSC represents our state with dignity in the international arena: the company’s products are marketed in more than 20 countries of the […]
Farmak JSC received a Letter of gratitude from the Chairman of Committee on Public Health of the Verkhovna Rada of Ukraine for timely assistance during the elimination of the emergency situation in Chernihiv region caused by the explosion of ammunition warehouses near the town of Ichnia. Farmak often receives letters of gratitude as it always […]